Experience

Davis Polk is advising Tencent in connection with its investment in Kuaikan World (Cayman) Limited. Tencent subscribed for Series E preferred shares issued by Kuaikan and purchased…

Davis Polk advised the joint lead managers in connection with the issue of $300 million floating-rate senior bonds due 2022 and €200 million 0.625% senior bonds due 2022 by DFZQ. Listed on…

Davis Polk is advising Duff & Phelps as financial adviser to the Board of Directors of Elanco Animal Health Incorporated in connection with its approximately $7.6 billion acquisition of…

Davis Polk advised the joint book-running managers in connection with the SEC-registered offering by Deciphera Pharmaceuticals, Inc. of 10,810,810 shares of common stock for gross proceeds…

Davis Polk advised the underwriters in connection with an SEC-registered offering by The Hartford Financial Services Group, Inc. of $600 million aggregate principal amount of its 2.800%…

Davis Polk advised the underwriters on the SEC-registered initial public offering by 9F Inc. of 8,900,000 American Depositary Shares, consisting of 6,750,000 ADSs sold by 9F and 2,150,000…

Davis Polk advised Exxon Mobil Corporation on the SEC-registered offering of $750 million principal amount of floating-rate notes due 2022, $750 million principal amount of 1.902% notes due…

Davis Polk advised the underwriter in connection with a block trade of 12,500,000 common shares of Genpact Limited by funds affiliated with Bain Capital Investors, LLC and its co-investor…

Davis Polk advised the joint book-running managers and the lead manager in connection with a $258.8 million public offering of common stock by Portola Pharmaceuticals, Inc. The common stock…

Davis Polk acted as special product counsel to the representatives of the initial purchasers in connection with a Rule 144A offering by Workiva Inc. of $300 million aggregate principal…